Menu

Search

Barbara Mintzes

Barbara Mintzes

Senior Lecturer, Faculty of Pharmacy, University of Sydney
Dr Barbara Mintzes is a research scientist specialising in the study of pharmaceutical policy. Her research focuses on the effects of direct-to-consumer advertising of prescription drugs and other forms of pharmaceutical promotion on the prescribing and use of medicines. She also performs systematic reviews of clinical trial evidence regarding the health effects of medicines, including both benefit and harm, in terms of outcomes of importance to patients’ health. Dr Mintzes has
has a doctorate in Health Care and Epidemiology and was Associate Professor at the School of Population and Public Health at the University of British Columbia (UBC), Canada prior to joining the University of Sydney in April 2015. At UBC, she worked with the Therapeutics Initiative, a research group that evaluates new drugs as a background to provincial reimbursement decisions and produces an educational bulletin on drug treatments. Currently, she is the lead investigator on an international comparative study examining the influence of national regulations on the amount of safety information that pharmaceutical sales representatives provide to primary care physicians. Dr Mintzes was a lead member of an international WHO and Health Action International (HAI) project that involved developing an educational manual on drug promotion, for pharmacy and medical students. This manual has been translated into Spanish, Russian and French, and incorporated into education curricula in a range of settings. Dr Mintzes maintains strong community engagement, having worked for many years with women’s health and consumer groups, including DES (diethylstilbestrol) Action Canada, and Women and Health Protection (a Canadian non-profit organization). She co-authored the book “Sex, Lies and Pharmaceuticals” with Ray Moynihan, published in 2010.

Drug companies pay doctors over A$11 million a year for travel and education

May 24, 2024 10:25 am UTC| Insights & Views Business

Drug companies are paying Australian doctors millions of dollars a year to fly to overseas conferences and meetings, give talks to other doctors, and to serve on advisory boards, our research shows. Our team analysed...

Opioid marketing to Canadian doctors hyped benefits, downplayed harms

Mar 10, 2020 11:54 am UTC| Health

Between January 2016 and June 2019 there were over 13,900 deaths from opioid overdoses in Canada, 4,500 of which occurred in 2018. Based on information to date, 2019 is likely to have a similar mortality rate. Most deaths...

1 

Economy

Asian Currencies Hold Steady Amid U.S.-Iran Ceasefire Hopes and Soft U.S. Inflation Data

Asian currencies traded within a narrow range on Wednesday as investors awaited further developments in U.S.-Iran ceasefire negotiations, while softer-than-expected U.S. inflation data offered modest relief to markets. The...

Gold Prices Ease From One-Month High Amid Iran Ceasefire Uncertainty

Gold prices slipped slightly from a one-month peak during Asian trading on Wednesday, with investors closely watching developments between the United States and Iran as a fragile ceasefire deadline approaches next week....

Strait of Hormuz Oil Shipments Resume Amid U.S.-Iran War Tensions

Global energy markets remain on edge as the U.S. blockade on Iranian ports continues to disrupt shipping through the Strait of Hormuz, a critical chokepoint that normally handles roughly one-fifth of worldwide oil and gas...

Asian Stocks Rally on Tech Gains and U.S.-Iran Diplomacy Hopes

Asian equity markets extended their winning streak on Wednesday, buoyed by strong performances in technology stocks and growing optimism surrounding potential U.S.-Iran diplomatic talks. The positive momentum followed a...

Iran War Drives Asia's Plastic Crisis — and a Green Packaging Boom

The ongoing Iran conflict is reshaping the global packaging industry in ways environmental advocates never anticipated. By disrupting Middle Eastern oil and petrochemical supplies, the war has driven plastic prices to...

Politics

Trump Administration Eyes Erica Schwartz as Next CDC Director Amid Leadership Overhaul

The White House is reportedly considering former Deputy Surgeon General Erica Schwartz as its next nominee to lead the Centers for Disease Control and Prevention, according to a source familiar with ongoing internal...

Israel-Hezbollah War: Netanyahu Vows to Dismantle Militia and Secure Peace Through Strength

Israeli Prime Minister Benjamin Netanyahu announced Wednesday that the Israeli military is pressing forward with its offensive against Hezbollah in southern Lebanon, declaring that forces are on the verge of capturing Bint...

U.S. Signals Opposition to Bachelet's UN Secretary-General Bid

U.S. Ambassador to the United Nations Mike Waltz effectively undermined Michelle Bachelets campaign to become the next UN Secretary-General, expressing shared concerns with Republican Senator Pete Ricketts of Nebraska...

Russia Warns Europe Over Drone Supplies to Ukraine, Hints at Strikes

Russias defence ministry issued a stark warning on Wednesday, claiming that European nations increasing drone supplies to Ukraine are pushing themselves further into direct conflict with Moscow. The statement marks yet...

Russia's Uranium Proposal for Iran Rejected by the U.S., Kremlin Confirms

Kremlin spokesman Dmitry Peskov confirmed on Wednesday that the United States has turned down Russias offer to remove Irans stockpile of enriched uranium from the country a diplomatic move that Moscow had positioned as a...

Science

China vs. NASA: The New Moon Race and What's at Stake by 2030

The space race is back and this time, its a direct competition between the United States and China for dominance on the lunar surface. NASAs Artemis II mission recently made history when four astronauts flew farther into...

NASA Artemis II: First Crewed Moon Mission Since Apollo Takes Four Astronauts on 10-Day Lunar Journey

NASAs Artemis II mission launched Wednesday, marking humanitys return to crewed lunar exploration for the first time since the Apollo era. Carrying four astronauts aboard the Orion spacecraft, this historic 10-day mission...

NASA's Artemis II Mission: First Crewed Lunar Journey Since Apollo

NASAs Artemis II mission launched Wednesday, marking humanitys return to crewed lunar exploration for the first time since the Apollo era. Carrying four astronauts aboard the Orion spacecraft, this historic 10-day mission...

NASA's Artemis II Crew Arrives in Florida for Historic Moon Mission

The four astronauts chosen for NASAs Artemis II mission have touched down at Kennedy Space Center in Florida, marking the beginning of final launch preparations for the first crewed lunar journey in over 50 years. NASA...

SpaceX Pivots Toward Moon City as Musk Reframes Long-Term Space Vision

SpaceX CEO Elon Musk has revealed a significant shift in the companys near-term space exploration strategy, announcing that SpaceX is now prioritizing the development of a self-growing city on the Moon rather than focusing...

Technology

ASML Raises 2026 Revenue Outlook as AI Chip Demand Surges

ASML Holding N.V. lifted its full-year 2026 revenue forecast after the Dutch semiconductor equipment giant surpassed first-quarter profit and sales expectations. The results were fueled by accelerating AI-driven chip...

Federal Agencies Secretly Test Anthropic's AI Despite Trump Administration Ban

Despite a formal directive from President Donald Trump ordering federal agencies to stop using Anthropics artificial intelligence technology, multiple U.S. government bodies have been quietly evaluating the companys latest...

KKR's $820M Investment Fuels Samsung SDS AI Expansion, Sending Group Shares Soaring

Samsung Group stocks rallied sharply on Wednesday following KKRs announcement of a major strategic partnership with Samsung SDS, reigniting investor confidence in the conglomerates artificial intelligence and digital...

DEEPX Partners with Hyundai to Power Next-Gen AI Robots Ahead of IPO

South Korean AI chip startup DEEPX is deepening its collaboration with Hyundai Motor Group to build a cutting-edge computing platform for generative AI-powered robots. The initiative will be driven by the companys upcoming...

Anthropic Nears $800 Billion Valuation as Investor Confidence Surges

Anthropic, the artificial intelligence startup behind the Claude AI assistant, is reportedly fielding investment offers that could value the company at up to $800 billion. According to Business Insider, multiple venture...
  • Market Data
Close

Welcome to EconoTimes

Sign up for daily updates for the most important
stories unfolding in the global economy.